Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pollak

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
BMC Cancer|June 3, 2024
Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutritionTuck Seng Cheng, Urwah Noor, Eleanor Watts, et al.
Cancer Research Communications|January 30, 2023
Prospective associations of hemoglobin A<sub>1c</sub> and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition CohortPeter T Campbell, Christina C Newton, Eric J Jacobs, et al.
The Journal of Urology|September 10, 2025
Reply by AuthorsBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
Nature Communications|November 15, 2019
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinomaKarina Chan, Francis Robert, Christian Oertlin, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Breast Cancer Research : BCR|November 27, 2024
Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studiesJacob K Kresovich, Catherine Guranich, Serena Houghton, et al.
Blood|October 18, 2012
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort ConsortiumBrenda M Birmann, Marian L Neuhouser, Bernard Rosner, et al.
Elife|May 5, 2026
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergeticsDavid Papadopoli, Ranveer Palia, Predrag Jovanovic, et al.
Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
BMC Cancer|June 3, 2024
Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutritionTuck Seng Cheng, Urwah Noor, Eleanor Watts, et al.
Cancer Research Communications|January 30, 2023
Prospective associations of hemoglobin A<sub>1c</sub> and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition CohortPeter T Campbell, Christina C Newton, Eric J Jacobs, et al.
The Journal of Urology|September 10, 2025
Reply by AuthorsBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
Nature Communications|November 15, 2019
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinomaKarina Chan, Francis Robert, Christian Oertlin, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Breast Cancer Research : BCR|November 27, 2024
Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studiesJacob K Kresovich, Catherine Guranich, Serena Houghton, et al.
Blood|October 18, 2012
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort ConsortiumBrenda M Birmann, Marian L Neuhouser, Bernard Rosner, et al.
Elife|May 5, 2026
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergeticsDavid Papadopoli, Ranveer Palia, Predrag Jovanovic, et al.
Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.
Pageof 24